67.87MMarket Cap-4327P/E (TTM)
2.689High2.563Low12.90KVolume2.680Open2.660Pre Close33.80KTurnover0.13%Turnover RatioLossP/E (Static)25.71MShares3.85052wk High1.45P/B26.90MFloat Cap1.81052wk Low--Dividend TTM10.19MShs Float75862432.808Historical High--Div YieldTTM4.77%Amplitude0.806Historical Low2.620Avg Price1Lot Size
InspireMD Stock Forum
InspireMD Announces Submission of Premarket Approval Application to FDA Seeking U.S. Regulatory Approval of the CGuard™ Prime Carotid Stent System
PMA based on overwhelmingly positive results from the pivotal C-GUARDIANS clinical study that were first presented at LINC 2024 in May
U.S. commercial launch anticipated in H1 2025, if approved
TEL AVIV, Israel and MIAMI, Sept. 16, 2024 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NASDAQ:NSPR), developer of the CGuard™ Embolic Prev...
Reuters05/28/2024 08:53
Benzinga· 1 min ago
3 MINUTES AGO, 7:00 AM EST
VIA GLOBENEWSWIRE
Benzinga· 1 min ago
No comment yet